Durvalumab vs Propranolol

Durvalumab vs Propranolol: Overview

This comparison examines the pharmacological differences between Durvalumab and Propranolol.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Propranolol: Non-selective beta-adrenergic receptor blocker.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Propranolol — 3-6 hours.

Chemical Properties

Molecular Formula: Propranolol — C16H21NO2.

Molecular Weight: Propranolol — 259.3440 g/mol.

Type: Durvalumab — Antibody; Propranolol — Small molecule.